What Is the Value of a Dental Practice in 2026?

The most common mistake I see dental practice owners make is entering a sale conversation without knowing what their practice is worth to two completely different types of buyers. Not one number — two numbers. The individual buyer number and the DSO number. They are not the same math. They are not even the same type of transaction. And the gap between them, for a practice doing $1.5M in collections, can easily exceed $500,000 in realized value.

The 2026 dental M&A market is the most active it has been since 2021 — and the most selective. Understanding the landscape, knowing which buyer type fits your practice, and having enough runway to prepare is the difference between a good outcome and the best one available to you.

This post covers the full picture: real multiples by specialty, how individual buyouts work versus DSO partnerships, what buyers in each camp are hungry for right now, and the exact timeline you need to get in front of this properly.

How Dental Practice Value Is Actually Calculated

The dental industry largely moved away from the old “percentage of collections” formula a decade ago. The metric that dominates today’s market — particularly for any practice above $500K in annual revenue — is EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization. More specifically, adjusted EBITDA, which accounts for owner add-backs, non-recurring expenses, and normalized compensation.

The value of a dental practice is then expressed as a multiple of that adjusted EBITDA figure. A practice with $400,000 in adjusted EBITDA selling at a 6x multiple is a $2.4M transaction. The same practice at a 4x multiple is $1.6M. That difference — driven by who buys it and how well it’s positioned — is entirely within your control if you plan ahead.

For smaller or single-doctor practices, buyers and advisors sometimes still reference SDE (Seller’s Discretionary Earnings) — which adds back the owner’s total compensation on top of net income. SDE is typically a larger number than EBITDA and is more common in individual buyer transactions, where the buyer is planning to step in and replace the owner clinically. Either way, the calculation starts with your real financial picture, properly recasted.

The 2026 Valuation Landscape: Multiples by Specialty

Here is where the dental market actually sits in mid-2026. These are real ranges from closed transactions — not asking prices, not broker estimates, not peak-cycle 2021 numbers that sellers are sometimes still quoting.

Specialty	Individual Buyer Range	DSO / PE Range	Primary Value Drivers
General Practice	60–80% of collections	4x – 7x EBITDA	Hygiene recall %, payer mix, low patient concentration, digital workflow
Orthodontics	70–90% of collections	5x – 9x EBITDA	Case starts, aligner revenue, contract structure, multi-location
Periodontics	65–80% of collections	4x – 7.5x EBITDA	Referral network strength, implant placement volume, perio maintenance retention
Endodontics	65–80% of collections	4.5x – 8x EBITDA	Cone beam CT, rotary instrumentation, referral concentration below 30%
Oral Surgery	75–95% of collections	5x – 9x+ EBITDA	Implant volume, in-house anesthesia, hospital privileges, multi-surgeon setup
Multi-Location Group (3+ sites)	N/A — DSO or PE path	9x – 14x EBITDA	EBITDA above $2M, management depth, geographic density, clean cap table

A note on context: multiples from the 2019–2021 peak reached 13x–16x for large DSO-to-DSO transactions, and 7x for single-doctor GPs. Those numbers no longer reflect the current cost of capital environment. Today’s realistic ranges — 5x–7.5x for most GPs seeking a DSO buyer — represent a normalization, not a collapse. The window is still strong. It is just not infinite.

Individual Buyouts: How They Work and Who They’re Right For

An individual buyout — sometimes called a doctor-to-doctor or D2D transaction — is exactly what it sounds like: a clinician buyer, typically an associate dentist or a practice owner looking to expand, acquires your practice. This was the dominant model for decades before DSOs entered the picture, and it remains the most common path for practices under $2M in collections.

How individual buyout financing works

Individual buyers almost universally finance through SBA 7(a) loans, which allow qualified buyers to finance 90% or more of the purchase price with loan amounts up to $5 million. The SBA program has become more accessible over the past two years, which has expanded the pool of qualified individual buyers — but it also creates a mathematical ceiling on what they can offer. The loan amount is constrained by what the practice’s cash flow can service after the buyer pays themselves a clinical income. That ceiling is why individual buyers top out at 60–80% of collections for most GPs.

What individual buyers look for

• Transferability of the patient base. An individual buyer is stepping into your shoes clinically. They need confidence that patients will stay through the transition, which is why seller commitment to a 6–24 month transition period directly influences the offer. Longer, more committed transitions support higher pricing.
• Clean, simple operations. A solo-buyer doesn’t have a corporate infrastructure to absorb complexity. Multiple locations, unusual payer structures, or high staff turnover make individual transactions harder to underwrite.
• Cultural and geographic fit. Unlike DSOs, individual buyers often care deeply about practice philosophy, staff culture, and community ties — sometimes more than the financial profile. This cuts both ways: it can mean a faster, cleaner close with someone who truly wants to preserve what you built.

DSO Partnerships: The Landscape, the Appetite, and What They’re Actually Paying

DSO — Dental Service Organization — is the umbrella term for the corporate and private equity-backed platforms that have been consolidating dentistry for the past 15 years. In 2026, they represent roughly 25% of the US dental market by practice count, and they are still growing. The largest platforms — Heartland Dental (KKR-backed, ~2,500 offices), Aspen Dental (~1,000+ offices), Pacific Dental Services, MB2 Dental, Smile Brands — operate nationally. Below them is a deep middle market of regional and specialty-focused DSOs actively building density in specific geographies.

Buyer appetite in 2026: what the data shows

According to Q2 2026 market data, 69% of DSOs plan to increase their acquisition activity this year. At the same time, the supply of premium practices coming to market has tightened — DSOs are competing harder for fewer qualifying opportunities. That combination creates real negotiating leverage for prepared sellers right now, because buyers need to transact before their own recapitalization cycles arrive. An estimated 78% of surveyed DSOs anticipate recapitalizations within the next 12–36 months, which means their acquisition mandates are time-sensitive.

What DSOs are actually buying

DSO acquisition criteria have tightened since the 2021 peak. The practices commanding top-of-range multiples in 2026 share specific characteristics:

• Low owner dependence. The practice should not live and die with the selling dentist. If 80% of production comes from you personally, DSOs will apply a significant discount or require a longer post-close employment commitment. A strong associate or multi-provider setup changes this math materially.
• Strong hygiene revenue. Recall percentage and hygiene production as a share of total collections is a primary underwriting metric. Hygiene represents recurring, predictable revenue — the kind of cash flow DSO financial models reward most.
• Clean payer mix. Practices with a healthy commercial insurance and fee-for-service mix command better multiples than those heavily weighted toward Medicaid or HMO plans.
• Modern technology and facility. Digital radiography, CBCT, CAD/CAM, and lease terms with runway — these reduce the capital DSOs need to deploy post-close and directly affect their underwriting.
• Scale and location. Urban and suburban markets, and practices above $1.5M in collections, attract the most buyers. A practice in a DSO’s target geography — particularly where they’re trying to build density — will see above-average offer activity.

DSO deal structure: what the term sheet actually looks like

The headline EBITDA multiple is only the starting point. DSO transactions typically include:

• Cash at close: Usually 60–80% of total deal value paid immediately at closing. This is the certainty component — liquid and not contingent on anything post-close.
• Rollover equity: 15–30% of the deal value retained as ownership in the DSO platform. If the DSO is later sold to private equity at a higher multiple — which most are structured to do — this equity can appreciate significantly. It’s the upside bet and the reason some sellers walk away with more than the headline price suggests.
• Employment terms: You remain as a clinician for a negotiated term, typically 2–5 years, at a market-rate associate compensation. The comp, the non-compete geography and duration, and the clinical autonomy provisions are all negotiable — and most sellers under-negotiate them.

Individual Buyer vs. DSO: Which Path Actually Wins?

There is no universal answer — but there is a framework for thinking about it honestly. The gap between individual buyer and DSO pricing for a typical GP doing $1.5M in collections is real and often substantial. A practice at $1.5M collections with 30% EBITDA margin ($450K adjusted EBITDA) might clear $900K–$1.2M in a D2D transaction and $2.25M–$3.15M in a DSO transaction. That’s not a small difference.

But total realized value isn’t just the check at closing. It includes post-close employment compensation (often $200K–$350K per year as an associate), the value of the rollover equity if the DSO recapitalizes, and the tax treatment of the deal structure — which varies meaningfully between an asset purchase agreement (most individual transactions) and the equity structures common in DSO deals.

The cases where an individual buyer produces a comparable or better total outcome tend to share certain features: the practice is in a rural or underserved market where DSO interest is limited, the seller prioritizes a short transition and immediate full exit, or the practice culture and patient relationships are tied to the owner in a way that would significantly disrupt value under corporate ownership.

How Much Time Do You Actually Need?

This is the question most practice owners ask too late. The honest answer is: the ideal preparation window is 24–36 months before you want to close. That’s not a conservative estimate padded for liability — it’s the timeline that actually lets you move the numbers that matter.

Here’s how that timeline breaks down in practice:

What if you don’t have 24–36 months?

Shorter timelines are absolutely workable — they just change the strategy. If you have 12 months, you focus exclusively on the improvements that move quickly: financial recast, hygiene recall optimization, lease documentation, and getting the right buyer relationships started. If you have 6 months or less, you’re optimizing the process rather than the practice — and that means making sure you go to market correctly, with the right positioning, in front of the right buyers, with full documentation ready on day one. The difference between a rushed sale and a well-run quick sale is almost entirely process.

The Bottom Line: Know Your Numbers Before Anyone Else Does

The value of your dental practice in 2026 is not a fixed number. It’s a range — and the range is defined by how prepared you are, which buyer pool you fit, and whether the process you run creates competition or closes it off. Most dentists who get the best outcomes aren’t the ones who had the most profitable practices. They’re the ones who understood their position, gave themselves enough runway, and ran a process that gave multiple buyers a reason to compete.

The first step is always the same: understand what you actually have, before anyone on the buy side does. That information is free. The cost of not having it isn’t.